Where clinical depth
meets strategic clarity.

Leading AI strategy and innovation at one of the world’s most trusted medical imaging companies — a global leader in enterprise imaging across radiology, pathology, and orthopaedics.

Built the AI commercial pipeline from the ground up — growing active AI opportunities from a single engagement to dozens across the global customer base. Translated emerging AI capabilities into clinical strategy and commercial traction at enterprise scale.

Instrumental in winning Sectra’s largest customer to date: Santé Québec — a province-wide enterprise PACS deployment covering the entire Quebec health system on Microsoft Azure. A scale of enterprise imaging not seen anywhere in the world. Working directly with SQ physicians on strategic AI research and clinical innovation for AI adoption at provincial scale.

Took ownership of customer success — including relationships requiring active turnaround. Rebuilt trust and deepened executive engagement with health systems that demanded senior, experienced leadership to navigate complex, high-stakes deployments.

Led advanced deployment initiatives that required deep product and clinical collaboration — complex go-lives and technical integrations that pushed beyond the standard playbook, drawing on extensive prior experience to guide teams and customers through challenges with no precedent in the local market.

Recognized as a thought leader by CIFAR and the Canadian Association of Radiologists — advising both organizations on the state of AI in diagnostic imaging and proposing adoption strategy for health systems at scale.

Led Sectra's first clinical AI deployment at William Osler Health System — pitching the application strategy directly to executive and clinical leadership, earning credibility by speaking the language of every stakeholder in the room simultaneously: clinical outcomes, technical risk, and executive ROI. Where a comparable Ontario health system's previous AI deployment took 3 years, the full deployment cycle at William Osler — from workflow design through retrospective quality check, shadow mode, and live clinical use — was completed in 6 weeks. The difference was preparation: aligning executive, radiology, and ED leadership before a single line of code was deployed.

A deliberate step into Silicon Valley-style company building — venture-backed, founder-led, moving at a speed that enterprise healthcare rarely tolerates. The discipline of startup velocity, under simultaneous investor and clinical customer scrutiny, is a different discipline from enterprise leadership — one that directly informs how Borealis Health advises founders navigating the same pressures.

Arterys launched the world's first FDA-cleared, pixel-level AI Software as a Medical Device (SaMD) — a watershed regulatory milestone for an entire category (2018). A decade of cloud-native architecture before most vendors had even started the conversation.

Tripled the addressable market through strategic repositioning. Deepened enterprise relationships with leading academic medical centres and health systems across the United States, Canada, and internationally.

Led expansion of the clinical AI suite from cardiac into MSK, Neuro, and Oncology — not by volume, but by curation. Assembled a clinical advisory board to identify and select the highest-value algorithms across four imaging specialties. From that field, a focused cohort was selected for deep integration into actual physician workflow — full brain evaluation, multi-model selection, integrated to MVP across all four specialties faster than anyone in the market had done. The result was not a catalogue of AI tools. It was a coherent clinical AI architecture that remains, to this day, the clearest working example of what the future of diagnostic imaging looks like — and that underlying technology stack continues to be leveraged in healthcare in new forms.

Partnered with clinical, engineering, and regulatory teams to translate complex AI model outputs into explainable, workflow-embedded clinical tools — setting a product standard that shaped subsequent FDA submissions across the industry.

Co-designed cutting-edge AI UX with University of California San Diego — led by Albert Hsiao, MD, PhD, one of the most intellectually rigorous people in the field. Dr. Hsiao taught a deeper understanding of cardiac MRI and the clinical reasoning that AI must earn the right to augment. Working at the research-to-production frontier on how radiologists actually interact with AI outputs in a live clinical workflow, the collaboration shaped how Arterys approached explainability, interface design, and radiologist trust — design principles that remain central to how Borealis Health advises health tech founders building clinical AI today.

Built a lasting clinical mentorship with Michael C. Muelly, M.D. — Clinical Assistant Professor of Radiology at Stanford University, Co-founder & CTO of IMVARIA, and former Google AI Research (Healthcare). The relationship forged at Arterys represents the kind of deep mutual respect that only develops when product and clinical reality are built together from the ground up. Dr. Muelly continues as a trusted mentor and clinical sounding board for Borealis Health.

Led the strategic shift from departmental PACS to enterprise health system strategy — reorienting product narrative, sales motion, and executive relationships toward the C-suite.

Founded and built Stratus — a cloud-native enterprise imaging platform on Google Cloud, one of the earliest production-grade cloud PACS platforms in the North American market. Influenced architecture and direction from the ground up.

Ran a simultaneous build-or-buy exercise for zero-footprint viewer technology — two independent internal development teams competed against each other in parallel while an external market diligence process evaluated commercial alternatives. The internal competition created urgency and a real benchmark. The market diligence narrowed the field to two high-conviction contenders: Arterys and Nucleus.io. Change Healthcare ultimately acquired Nucleus.io — a decision informed by rigorous internal and external evaluation running concurrently. This is the kind of structured competitive pressure that produces better decisions faster.

Executed a 60-practice clinical study across 30 IDNs and 30 independent practices — the definitive clinical evidence and go-to-market foundation, and where the operating principle of trusting data over assumption was forged.

Represented the company directly with health system leadership across the US: rebuilding trust and leading onsite commercial teams through strategic tender processes.

Rose from Product Manager to Senior Global Marketing Manager over 16 years, managing IMPAX — a $693M revenue PACS platform — across 70+ countries. Led R&D groups as large as 200 people.

Led product for much of IMPAX 6 — one of the most widely deployed enterprise radiology platforms in the world. Then led product and marketing strategy for Enterprise Imaging from cradle through US launch — two of health IT's most significant platforms, built and taken to market from the inside.

Executed one of health IT's most significant product turnarounds: stepped in after a year of failed leadership, a programme 12 months over schedule with €170M in missed revenues. Delivered the release. Rebuilt go-to-market strategy, competitive positioning, and global marketing execution across EMEA, North America, and APAC.

Won marquee accounts including Stanford Medicine, UMass Medical System, London Health Sciences Centre, and Northwestern Medicine — validating clinical credibility at the highest levels of academic medicine.

Thousands of hours invested alongside physicians across specialties — understanding clinical workflow at the level of individual keystrokes and cognitive load. The clinical proximity accumulated here is the foundation that makes every subsequent role possible.

First role in health tech — emerging from Silicon North, the Waterloo region's golden era of technology innovation. Waterloo's position as a global tech hub is not accidental: the University of Waterloo brings together one of the world's largest concentrations of math, computer science, and engineering talent, and channels it into industry through a co-op network spanning 8,000+ employers in 70+ countries. The region consistently ranks as #1 small tech talent market in North America. Mitra Imaging was ground zero for radiology's shift from film to digital — and a direct product of that talent engine.

Grew up professionally under Eric L. Peterson (C.M., Order of Canada) — an environment that was intellectually rigorous, mission-driven, and world-class. It remains the single most formative chapter of the career.

Hands-on UX training with Alan Cooper — the Father of Visual Basic and author of The Inmates Are Running the Asylum — as part of the team designing the future of digital radiology. Cooper trained the team on his methodology, we applied it, he critiqued it, and we iterated — the full design engagement cycle. Silicon Valley thinking, Northern execution. Cooper's central argument: technologists build products for themselves, not users. That lesson has shaped every product and UX decision since.

Early team that revolutionized healthcare imaging interoperability. Built foundational fluency in HL7, DICOM, and HIS-to-modality integration from 1997 — experience that now spans 29 years of continuous innovation in the space.

Relocated to Eindhoven, Netherlands to build and lead Mitra's European operations from the ground up — selling, deploying, and regionalizing products and services across European markets. Recruited the first European technical team, who went on to long successful careers through the Agfa acquisition. An orientation that has defined every role since: building for the world, not just the market where you happen to sit.